KYTHERA BIOPHARMACEUTICALS INC Interest Expense
KYTHERA BIOPHARMACEUTICALS INC reported Interest Expense of $1.35 million for the 3-month period ending 2015-06-30, per its 10-Q filed 2015-08-06.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2015-08-06
- KYTHERA BIOPHARMACEUTICALS INC interest expense for the quarter ending 2015-06-30 was $1.35M, a 11.60% increase year-over-year.
- KYTHERA BIOPHARMACEUTICALS INC interest expense for the quarter ending 2015-03-31 was $1.08M, a 64.98% increase year-over-year.
- KYTHERA BIOPHARMACEUTICALS INC interest expense for the quarter ending 2014-12-31 was $1.12M, a 127.53% increase year-over-year.
- KYTHERA BIOPHARMACEUTICALS INC interest expense for the quarter ending 2014-09-30 was $1.17M, a 118.25% increase year-over-year.
- KYTHERA BIOPHARMACEUTICALS INC interest expense for fiscal 2014 was $4.16M, a 109.95% increase from fiscal 2013.
- KYTHERA BIOPHARMACEUTICALS INC interest expense for fiscal 2013 was $1.98M, a 348.98% increase from fiscal 2012.
- KYTHERA BIOPHARMACEUTICALS INC interest expense for fiscal 2012 was $441.00K, a 488.00% increase from fiscal 2011.
- KYTHERA BIOPHARMACEUTICALS INC interest expense for fiscal 2011 was $75.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2015-06-30 | $1.35M 10-Q · filed 2015-08-06 | $2.43M 10-Q · filed 2015-08-06 | $3.55M derived: sum of 3 quarters · filed 2015-08-06 | $4.72M derived: sum of 4 quarters · filed 2015-08-06 |
| 2015-03-31 | $1.08M 10-Q · filed 2015-05-07 | $2.20M derived: sum of 2 quarters · filed 2015-05-07 | $3.38M derived: sum of 3 quarters · filed 2015-05-07 | $4.58M derived: sum of 4 quarters · filed 2015-08-06 |
| 2014-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $2.30M derived: sum of 2 quarters · filed 2015-03-02 | $3.50M derived: sum of 3 quarters · filed 2015-08-06 | $4.16M 10-K · filed 2015-03-02 |
| 2014-09-30 | $1.17M 10-Q · filed 2014-11-10 | $2.38M derived: sum of 2 quarters · filed 2015-08-06 | $3.03M 10-Q · filed 2014-11-10 | $3.53M derived: sum of 4 quarters · filed 2015-08-06 |
| 2014-06-30 | $1.21M 10-Q · filed 2015-08-06 | $1.86M 10-Q · filed 2015-08-06 | $2.35M derived: sum of 3 quarters · filed 2015-08-06 | $2.89M derived: sum of 4 quarters · filed 2015-08-06 |
| 2014-03-31 | $654.00K 10-Q · filed 2015-05-07 | $1.15M derived: sum of 2 quarters · filed 2015-05-07 | $1.69M derived: sum of 3 quarters · filed 2015-05-07 | $2.24M derived: sum of 4 quarters · filed 2015-05-07 |
| 2013-12-31 | $494.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $1.03M derived: sum of 2 quarters · filed 2015-03-02 | $1.58M derived: sum of 3 quarters · filed 2015-03-02 | $1.98M 10-K · filed 2015-03-02 |
| 2013-09-30 | $537.00K 10-Q · filed 2014-11-10 | $1.09M derived: sum of 2 quarters · filed 2014-11-10 | $1.49M 10-Q · filed 2014-11-10 | $1.74M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $553.00K 10-Q · filed 2014-08-07 | $948.00K 10-Q · filed 2014-08-07 | $1.21M derived: sum of 3 quarters · filed 2015-03-02 | $1.28M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $395.00K 10-Q · filed 2014-05-08 | $654.00K derived: sum of 2 quarters · filed 2015-03-02 | $732.00K derived: sum of 3 quarters · filed 2015-03-02 | $784.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $259.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $337.00K derived: sum of 2 quarters · filed 2015-03-02 | $389.00K derived: sum of 3 quarters · filed 2015-03-02 | $441.00K 10-K · filed 2015-03-02 |
| 2012-09-30 | $78.00K 10-Q · filed 2013-11-14 | $130.00K derived: sum of 2 quarters · filed 2013-11-14 | $182.00K 10-Q · filed 2013-11-14 | |
| 2012-06-30 | $52.00K 10-Q/A · filed 2013-09-27 | $104.00K 10-Q/A · filed 2013-09-27 | ||
| 2012-03-31 | $52.00K 10-Q/A · filed 2013-09-27 | |||
| 2011-12-31 | $75.00K 10-K · filed 2014-03-17 |